Dr. Shao Guang Liu | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Dr. Shao Guang Liu | Medicine | Best Researcher Award

Dr. Shao Guang Liu | Associate Professor | Gansu Provincial Hospital | China

Dr. Liushaoguang is an accomplished associate professor and clinical expert in trauma and emergency medicine, currently contributing to the advancement of medical research and patient care at Gansu Provincial Hospital. His research primarily focuses on emergency trauma management and sepsis-induced peritonitis, with a strong emphasis on molecular and immunological mechanisms underlying trauma-related complications. Dr. Liushaoguang has led and completed several significant provincial-level projects, including studies on the construction of trauma care system management models and investigations into dendritic cell function transformation and immune paralysis in sepsis. His scholarly contributions reflect a deep integration of clinical insight and biomedical research aimed at improving critical care outcomes. His work has been widely recognized in academic circles, with a citation record of 160 citations across 11 documents and an h-index of 6 on Scopus, demonstrating the impactful nature of his research. On Google Scholar, his publications have also garnered substantial attention from the scientific community. In addition to his research achievements, Dr. Liushaoguang serves on the editorial board of the Chinese Journal of Traumatology, further underscoring his commitment to advancing medical knowledge. His published works explore various aspects of sepsis, endothelial function, gene methylation, and circular RNA mechanisms in inflammatory responses.

Profile

Scopus

Featured Publications

  • Liushaoguang. (2023). Four differentially methylated gene pairs to predict the prognosis for early stage. Frontiers in Genetics.

  • Liushaoguang. (2023). Circular RNA circ_0001105 protects the intestinal barrier of septic rats by inhibiting inflammation. BMC Gastroenterology.

  • Liushaoguang. (2022). Transcriptomics changes in the peritoneum of mice with lipopolysaccharide-induced peritonitis. Scientific Reports.

  • Liushaoguang. (2022). Endothelial progenitor cell-derived exosomal miRNA-31 alleviates septic peritonitis. Cell Death Discovery.

  • Liushaoguang. (2021). Research on the construction of the trauma care system management model in Gansu Province. Chinese Journal of Traumatology.

Dr. Lova Kajuluri | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Dr. Lova Kajuluri | Medicine | Best Researcher Award

Postdoctoral Research Fellow, Mass General Brigham, United States

Lova Prasadareddy Kajuluri is a Postdoctoral Research Fellow at the Cardiovascular Research Center, Massachusetts General Hospital (MGH), Charlestown, USA. He is recognized for his significant contributions to cardiovascular research, particularly in understanding vascular calcification and its potential treatments. With a strong background in biotechnology, Kajuluri has advanced in his research career through various prestigious roles in both India and the United States. He holds a Doctorate in Science from the CSIR-Central Drug Research Institute, Lucknow, India, and has received multiple research grants to further his studies in cardiovascular diseases. 🚀

Publication Profile

Education Background

Kajuluri’s educational journey began with a Bachelor of Science in Biotechnology, Biochemistry, and Chemistry from Andhra University in 2007. He continued to pursue a Master of Science in Biotechnology from Andhra University, followed by a Ph.D. in Science from CSIR-Central Drug Research Institute, India. His academic excellence has paved the way for several postdoctoral positions, starting from his research fellowship at Boston University to his current position at Massachusetts General Hospital, where he continues to explore novel therapies in cardiovascular research. 🎓📚

Professional Experience

Kajuluri’s professional career began as a Research Fellow at CSIR-Central Drug Research Institute in India, focusing on Leishmaniasis and actin-related proteins. He transitioned to postdoctoral research at Boston University, where he led studies on vascular smooth muscle contraction and calponin. His current role as a Postdoctoral Research Fellow at MGH involves leading studies on vascular calcification, gene therapy, and identifying therapeutic targets to treat cardiovascular diseases. His extensive research in these areas contributes significantly to the advancement of vascular health. 🔬🧑‍🔬

Awards and Honors

Kajuluri has received numerous prestigious awards throughout his career. Notably, he was awarded the Research Fellowship from the University Grants Commission, New Delhi, India (2011-2016). He has also been a part of several funded research projects, including those supported by the National Heart, Lung, and Blood Institute, USA. His dedication to advancing cardiovascular and infectious disease research has earned him recognition from the scientific community. 🏆🎖️

Research Focus

Kajuluri’s research is focused on understanding the molecular mechanisms underlying vascular calcification, a condition that contributes to cardiovascular diseases. His current studies explore gene therapies to treat vascular calcification in infants, as well as the role of histone deacetylases in vascular health. Additionally, his earlier work in Leishmaniasis has expanded his expertise to parasitology and cellular biology. His work bridges cardiovascular research and therapeutic innovation, offering potential treatments for critical vascular conditions. ❤️🧬

Conclusion

Lova Prasadareddy Kajuluri’s career is a testament to his commitment to advancing science in cardiovascular health and infectious diseases. Through his research, he continues to provide invaluable insights into vascular calcification and gene therapy, offering hope for future treatments in these fields. 🌟🔬

Publication Top Notes

Epigenetic Regulation of Human Vascular Calcification. Genes, 2025, 16, 506. DOI

Calponin 1 inhibits agonist-induced ERK activation and decreases calcium sensitization in vascular smooth muscle.  Journal of Cellular and Molecular Medicine, January 28, 2024. PubMed

Treatment of calcific arterial disease via enhancement of autophagy using GSK343.  iScience, October 28, 2023. PubMed

Intracellular localization of MyosinXXI discriminates Leishmania spp and Leptomonas seymouri.  Biochemical and Biophysical Research Communications, May 14, 2022. PubMed

Actin-related protein 4: An unconventional negative regulator of mitochondrial calcium in protozoan parasite Leishmania.  Mitochondrion, Jan 2022. PubMed

Vascular aging, the vascular cytoskeleton and aortic stiffness.  Exploration of Medicine, June 2021. PubMed

The uterine myocyte, contractile machinery and proteins of the myometrium and their relationship to the dynamic nature of myometrial function.  Current Opinion in Physiology, February 2020. ScienceDirect

A twinfilin-like protein coordinates karyokinesis by influencing mitotic spindle elongation and DNA replication in Leishmania.  Molecular Microbiology, April 2016. PubMed

Oligomerization of coronin: Implication on actin filament length in Leishmania. Cytoskeleton (Hoboken, N.J.), December 2015. PubMed